# Regulation of Cues vs Cognitive Behavioral Therapy for Binge Eating and Weight Loss Among Veterans: A Feasibility and Randomized Clinical Trial

## TL;DR

A new therapy called ROC+BWL reduced binge eating more than traditional CBT in veterans with obesity, but weight loss benefits faded over time.

## Contribution

ROC+BWL shows greater efficacy than CBT in reducing binge eating among veterans with obesity, particularly for those with binge eating disorder.

## Key findings

- ROC+BWL reduced binge eating more than CBT during treatment and at 6-month follow-up.
- Weight loss benefits of ROC+BWL were not sustained at follow-up.
- Results were stronger for veterans with clinical binge eating disorder.

## Abstract

Can the regulation of cues (ROC) treatment reduce binge eating and weight among veterans more than cognitive behavioral therapy (CBT)?

In this randomized clinical trial with 129 veterans with binge eating and overweight or obesity, analysis showed that ROC reduced binge eating and weight more than CBT during the 5 months of treatment, and the binge eating reductions, but not weight reductions, were maintained at the 6-month follow-up. Results were more pronounced in individuals with binge eating disorder.

These finding suggest that the ROC program targeting appetitive traits could be an effective treatment to reduce binge eating among veterans, although trials with longer follow-up are needed.

This randomized clinical trial evaluates the feasibility and efficacy of a regulation of cues with behavioral weight loss intervention compared with cognitive behavioral therapy (CBT) to reduce body mass index and binge eating episodes among veterans with overweight or obesity and clinical or subthreshold binge eating disorder.

Cognitive behavioral therapy (CBT) has the most empirical support for treatment of binge eating. Appetitive traits, including food responsiveness and satiety responsiveness, impact how individuals interact with the current obesogenic environment. The regulation of cues (ROC) plus behavioral weight loss (BWL) intervention was specifically developed to target food responsiveness, satiety responsiveness, and energy reduction.

To evaluate the feasibility and efficacy of ROC+BWL and CBT over 5 months of treatment and 6 months of follow-up and to explore whether clinical binge eating was a moderator of outcomes.

This randomized clinical trial was conducted from March 2019 to April 2023 among veterans at a university clinic. Eligible participants were veterans who met criteria for Binge Eating Disorder (BED) or subthreshold BED, had a body mass index (BMI; calculated as weight in kilograms divided by height in meters squared) of 25 to 45, were aged 18 to 65 years, and were free of other exclusionary criteria. Data were analyzed from January 2024 to June 2025.

The ROC+BWL intervention uniquely targets food responsiveness, satiety responsiveness, and energy reduction. CBT focuses on disrupting the dietary restraint/binge eating cycle by changing maladaptive thoughts and behaviors. Participants were randomized to receive either ROC+BWL or CBT for 5 months.

The main outcomes were feasibility and change in binge eating (measured as loss of control) and body weight, assessed at midtreatment (2.5 months), posttreatment (5 months), and a 6-month follow-up (11 months).

A total of 1853 veterans inquired about participation and 1724 were excluded or declined to participate. The final sample included 129 veterans (mean [SD] age, 47.1 [11.3] years; 76 [59%] male; mean [SD] BMI, 34.8 [4.7]), with 63 randomized to ROC+BWL and 66 to CBT. A total of 123 veterans (95%) provided data posttreatment, and 115 veterans (89%) provided data at the 6-month follow-up. Attendance and acceptability ratings did not differ between treatments. ROC+BWL resulted in a greater reduction in risk of binge eating than CBT at midtreatment (difference in probability, −0.20; 95% credible interval [CrI], −0.30 to −0.11), posttreatment (difference in probability, −0.23; 95% CrI, −0.22 to −0.19), and at the 6-month follow-up (difference in probability, −0.21; 95% CrI, −0.21 to −0.18). ROC+BWL also resulted in greater weight loss at midtreatment (difference in BMI change, −0.68; 95% CrI, −1.23 to −0.12) and posttreatment (difference in BMI change, −0.71; 95% CrI, −1.40 to −0.01) assessments than CBT, but significant differences were no longer observed at the 6-month follow-up (difference in BMI change, −0.22; 95% CrI, −0.98 to 0.54). Results were more pronounced among veterans with BED.

In this randomized clinical trial among veterans with binge eating and obesity, ROC+BWL resulted in greater decreases in binge eating compared with CBT. Although ROC+BWL resulted in greater weight loss compared with CBT during treatment, these differences were not maintained. Thus, ROC+BWL could be an alternate model to treat BED among veterans, but effects on weight need further research.

ClinicalTrials.gov Identifier: NCT03678766